Kellner Capital’s Momenta Pharmaceuticals MNTA Stock Holding History
Bought
Maintained
Sold
Kellner Capital's MNTA Position: Q4 2020 in Review
Kellner Capital sold out of Momenta Pharmaceuticals (MNTA) in Q4 2020, closing a stake of 260,300 shares — an estimated $13.7M sold.
Kellner Capital first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $13.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Kellner Capital reported no remaining Momenta Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Kellner Capital sold 260,300 Momenta Pharmaceuticals shares in Q4 2020, an estimated $13.7M.
- Kellner Capital first reported a position in Momenta Pharmaceuticals in Q3 2020 and held it in 1 quarter.
- Kellner Capital's Momenta Pharmaceuticals position peaked at $13.7M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals as of Q4 2020.
Based on Kellner Capital's 13F filing for Q4 2020, filed 10 Feb 2021.